Profile

Only available on StudyMode
  • Topic: Executive director, Board of directors, Managing director
  • Pages : 6 (1166 words )
  • Download(s) : 23
  • Published : February 18, 2013
Open Document
Text Preview
Company profile Date of Establishment| 1935|
Revenue| 1386.83 ( USD in Millions )|
Market Cap | 249989.56450195 ( Rs. in Millions )|
Corporate Address| Mumbai Central,,Mumbai-400008, Maharashtra www.cipla.com|
Management Details| Chairperson - Y K Hamied
MD - Y K Hamied
Directors - Amar Lulla, H R Manchanda, K A Hamied, M K Hamied, M R Raghavan, Mital Sanghvi, Pankaj Patel, Ramesh Shroff, S A A Pinto, S Radhakrishnan, V C Kotwal, Y K Hamied| Business Operation| Pharmaceuticals & Drugs|

Background| Chemical, Industrial & Pharmaceutical Laboratories, now known as Cipla, was incorporated 1935.Khwaja Abdul Hamied, the founder of Cipla gave the company all his patent and proprietary formulas for several drugs and medicines, without charging any royalty. On August 17, 1935, Cipla was registered as a public limited company with an authorised capital of Rs 6 lakhs.| Financials| Total Income - Rs. 64338.8 Million ( year ending Mar 2011) Net Profit - Rs. 9603.9 Million ( year ending Mar 2011) |

Company Secretary| Mital Sanghvi|
Bankers| Bank of Baroda, Canara Bank , Corporation Bank, HSBC Bank, Indian Overseas Bank, Standard Chartered Bank, Union Bank of India| Auditors| RS Bharucha & Co, RGN Price & Co|
|
|

management

.No| Name| Designation |
|
1| Y K Hamied| Chairman| | | | | |
| |
3| Y K Hamied| Managing Director| | | | | |
| |
2| Mital Sanghvi| Company Secretary| | | | | |
| |
4| V C Kotwal| Non Executive Director| | | | | |
| |
5| H R Manchanda| Non Executive Director| | | | | | | |
6| M R Raghavan| Non Executive Director| | | | | |
| |
7| Ramesh Shroff| Non Executive Director| | | | | | | |
8| Pankaj Patel| Non Executive Director| | | | | |
| |
9| M K Hamied| Joint Managing Director| | | | | |
| |
10| S Radhakrishnan| Whole Time Director| | | | | | | |
|
|

Product

Company| Sales
(Rs.Million)| Current
Price| Change (%)| P/E Ratio| Market
Cap.(Rs.Million)| 52-Week
High/Low|
|
Sun Pharma Inds.| 31047.00| 497.65| 1.36| 32.26| 508418.96| 538/392| | | |
Dr Reddys Lab| 51874.00| 1554.80| 0.30| 25.74| 262818.71| 1855/1387| | | |
Cipla| 61351.60| 313.75| 0.77| 24.78| 249989.56| 381/274| | | |
Lupin| 45085.00| 448.65| 0.45| 24.00| 199447.09| 520/363| | | |
Ranbaxy Labs.| 56695.43| 458.40| 1.14| 0.00| 191271.37| 612/414| | | |
Glaxosmithkline Phar| 21116.43| 1983.65| -0.51| 40.58| 168880.88| 2475/1905| | | |
Cadila Healthcare| 29199.00| 712.55| -0.63| 23.91| 146814.93| 984/703| | | |
DiviS Lab| 13054.39| 712.15| -0.42| 19.57| 94902.63| 843/582| | | |
Glenmark Pharma| 12013.53| 309.50| -3.05| 37.90| 86329.27| 390/242| | | |
Biocon| 15315.62| 315.90| -0.72| 14.87| 63640.00| 431/302| | | |
Piramal Healthcare| 15853.60| 359.95| 0.00| 13.18| 60187.42| 550/342| | | |
Aventis Pharma| 10849.52| 2350.00| 0.05| 29.35| 54095.48| 2424/1710| | | |
Torrent Pharma| 17781.95| 569.05| 0.57| 17.09| 47877.34| 687/499| | | |
Wockhardt| 17549.24| 385.80| 0.23| 17.89| 42121.88| 473/303| | | |
Pfizer| 12434.83| 1252.15| -3.73| 23.78| 38811.78| 1636/1030| | | |
Jubilant LifeScience| 22008.96| 204.05| -1.28| 19.00| 34569.58| 315/148| | | |
Matrix Laboratories| 18818.24| 209.35| 0.00| 15.31| 32729.53| 211/209| | | |
Astrazeneca Pharma I| 5932.38| 1259.45| -3.74| 43.90| 32711.25| 1472/1080| | | |
Abbott India| 10368.73| 1482.75| -1.37| 42.42| 31945.14| 1700/1178| | | |
Ipca Laboratories| 19214.20| 243.95| -3.02| 12.06| 31621.45| 351/230| | | |
Novartis| 7086.43| 803.60| -1.96| 16.87| 26196.67| 944/585| | | |
Aurobindo Pharma| 41331.20| 82.35| -3.46|...
tracking img